EpiCeram's Unit Acquisition

EpiCeram raised a round of funding on November 14, 2011. Investors include PuraCap Pharmaceutical.

EpiCeram Skin Barrier Emulsion is a clinically-effective, steroid-free fragrance-free, non-greasy treatment for many dermatoses, including atopic dermatitis, allergic or irritant contact dermatitis, a…

Articles about EpiCeram's Unit Acquisition: